83 related articles for article (PubMed ID: 3717517)
1. Methotrexate as relapse therapy for rhabdomyosarcoma.
Bode U
Am J Pediatr Hematol Oncol; 1986; 8(1):70-2. PubMed ID: 3717517
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate infusion in low-risk gestational trophoblastic disease.
Wong LC; Ngan HY; Cheng DK; Ng TY
Am J Obstet Gynecol; 2000 Dec; 183(6):1579-82. PubMed ID: 11120531
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy for rhabdomyosarcoma of the orbit.
Sagerman RH; Cassady JR; Tretter P
Trans Am Acad Ophthalmol Otolaryngol; 1968; 72(6):849-54. PubMed ID: 4177896
[No Abstract] [Full Text] [Related]
4. Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Burke M; Anderson JR; Kao SC; Rodeberg D; Qualman SJ; Wolden SL; Meyer WH; Breitfeld PP;
J Clin Oncol; 2007 Nov; 25(31):4909-13. PubMed ID: 17971587
[TBL] [Abstract][Full Text] [Related]
5. Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas: pilot study for the upcoming European Rhabdomyosarcoma Protocol.
Casanova M; Ferrari A; Bisogno G; Merks JH; De Salvo GL; Meazza C; Tettoni K; Provenzi M; Mazzarino I; Carli M
Cancer; 2004 Oct; 101(7):1664-71. PubMed ID: 15378498
[TBL] [Abstract][Full Text] [Related]
6. [Intra-arterial chemotherapy of soft tissue sarcoma in children].
Hatae Y; Takeda T; Nakadate H; Nishi M; Kobayashi R; Yamawaki S; Isu K
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3271-5. PubMed ID: 3777963
[TBL] [Abstract][Full Text] [Related]
7. Rhabdomyosarcoma of the orbit.
Aviles E
Int Surg; 1974 May; 59(5):297-9. PubMed ID: 4418944
[No Abstract] [Full Text] [Related]
8. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
[TBL] [Abstract][Full Text] [Related]
9. Does the time-point of relapse influence outcome in pediatric rhabdomyosarcomas?
Mattke AC; Bailey EJ; Schuck A; Dantonello T; Leuschner I; Klingebiel T; Treuner J; Koscielniak E
Pediatr Blood Cancer; 2009 Jul; 52(7):772-6. PubMed ID: 19165889
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy combined with systemic chemotherapy of rhabdomyosarcoma in children: local control in patients enrolled in the Intergroup Rhabdomyosarcoma Study.
Tefft M; Lindberg RD; Gehan EA
Natl Cancer Inst Monogr; 1981 Apr; (56):75-81. PubMed ID: 7029298
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.
Wang S; An R; Han X; Zhu K; Xue Y
Gynecol Oncol; 2006 Dec; 103(3):1105-8. PubMed ID: 16870237
[TBL] [Abstract][Full Text] [Related]
12. [A infant case of rhabdomyosarcoma arising from the left iliac region with complete remission for 2 years after combination therapy].
Shimabuku M; Muto Y; Hokama A; Tokumine F; China K; Gushiken T; Sonan S; Hirayama K; Toda T
Gan To Kagaku Ryoho; 1993 Apr; 20(5):657-60. PubMed ID: 8470926
[TBL] [Abstract][Full Text] [Related]
13. [Bolus and maintenance infusion of high-dose methotrexate].
Amino K; Kawaguchi N; Matsumoto S; Manabe J; Tabata D; Machida M
Gan To Kagaku Ryoho; 1989 May; 16(5):2045-9. PubMed ID: 2730094
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
[TBL] [Abstract][Full Text] [Related]
15. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
[TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group.
Spunt SL; Smith LM; Ruymann FB; Qualman SJ; Donaldson SS; Rodeberg DA; Anderson JR; Crist WM; Link MP
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6072-9. PubMed ID: 15447992
[TBL] [Abstract][Full Text] [Related]
17. 42-hour methotrexate infusions as relapse therapy for childhood malignancies: toxicity and efficacy of 109 infusions.
Bode U; Erps M; Schiffer D
Pediatr Hematol Oncol; 1987; 4(1):15-24. PubMed ID: 3152909
[TBL] [Abstract][Full Text] [Related]
18. Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.
Plotkin SR; Betensky RA; Hochberg FH; Grossman SA; Lesser GJ; Nabors LB; Chon B; Batchelor TT
Clin Cancer Res; 2004 Sep; 10(17):5643-6. PubMed ID: 15355887
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology.
Canellos GP; Skarin AT; Rosenthal DS; Moloney WC; Frei E
Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience.
Moe PJ; Holen A; Nygaard R; Glomstein A; Madsen B; Hellebostad M; Stokland T; Wefring KW; Steen-Johnsen J; Nielsen B; Hapnes C; Børsting S
Pediatr Hematol Oncol; 2003; 20(3):187-200. PubMed ID: 12637215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
